Evidence map›Paper›PMID 29476333›Full record

ArticlePaediatric drugs2018

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials.

Mary A Ott, Francis P Crawley, Xavier Sáez-Llorens, Seth Owusu-Agyei, David Neubauer, Gary Dubin, Tatjana Poplazarova, Norman Begg, Susan L Rosenthal

Abstract read
In one paragraph

Article in Paediatric drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Comparing the Study Populations in Dietary Supplement and Drug Clinical Trials for Metabolic Syndrome and Related Disorders.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2019
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary A OttDivision of Adolescent Medicine, Department of Pediatrics, Indiana University School of Medicine and Department of Philosophy, IUPUI (adjunct), 410 West 10th Street, HS 1001, Indianapolis, IN, 46202, USA. maott@iu.edu.ORCID http://orcid.org/0000-0003-1347-2480
Francis P CrawleyGood Clinical Practice Alliance-Europe (GCPA), Brussels, Belgium.ORCID http://orcid.org/0000-0002-6893-5916
Xavier Sáez-LlorensPediatrics, Head of Infectious Diseases and Director of Clinical Research at Hospital del Niño Dr José Renán Esquivel, Panama City, Panama.
Seth Owusu-AgyeiEpidemiology, Institute of Health Research, University of Health and Allied Sciences, Ho, Ghana.
David NeubauerDepartment of Pediatrics, Medical Faculty and University Medical Centre Ljubljana, University of Ljubljana, Bohoričeva 20, Ljubljana, Slovenia.ORCID http://orcid.org/0000-0002-4564-5318
Gary DubinTakeda Pharmaceuticals, Glattpark-Opfikon, Zurich, Switzerland.
Tatjana PoplazarovaGSK Vaccines, Avenue Fleming 20, Parc de la Noire Epine, B-1300, Wavre, Belgium.ORCID http://orcid.org/0000-0002-1121-0236
Norman BeggGSK Vaccines, Avenue Fleming 20, Parc de la Noire Epine, B-1300, Wavre, Belgium.ORCID http://orcid.org/0000-0002-9441-1446
Susan L RosenthalMedical Psychology (in Pediatrics and Psychiatry), Columbia University Medical Center-College of Physicians and Surgeons, New York, NY, USA.

Funding

GlaxoSmithKline editorial supportGlaxoSmithKline None - GSK covered meeting costs
6 · The paper itself

Abstract

Children of minor parents are under-represented in clinical trials. This is largely because of the ethical, legal, and regulatory complexities in the enrolment, consent, and appropriate access of children of minor parents to clinical research. Using a case-based approach, we examine appropriate access of children of minor parents in an international vaccine trial. We first consider the scientific justification for inclusion of children of minor parents in a vaccine trial. Laws and regulations governing consent generally do not address the issue of minor parents. In their absence, local community and cultural contexts may influence consent processes. Rights of the minor parent include dignity in their role as a parent and respect for their decision-making capacity in that role. Rights of the child include the right to have decisions made in their best interest and the right to the highest attainable standard of health. Children of minor parents may have vulnerabilities related to the age of their parent, such as increased rates of poverty, that have implications for consent. Neuroscience research suggests that, by age 12-14 years, minors have adult-level capacity to make research decisions in situations with low emotion and low distraction. We conclude with a set of recommendations based on these findings to facilitate appropriate access and equity related to the participation of children of minor parents in clinical research.

Indexed as

AdolescentChildDecision MakingHumansInformed ConsentMinorsParents

Identifiers

PMID29476333
PMCPMC5954045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.